Chemomab Therapeutics Ltd. (CMMB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -11.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.9M | -5.13M | -7.4M | -7.12M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | - | - | - | - | 100% | 100% | 100% | 100% | 32.65% | 0.16% | -31.54% | -90.71% |
| Net Income | -1.91M | -1.75M | -2.1M | -3.31M | -2.99M | -3.49M | -3.62M | -3.91M | -3.45M | -4.07M | -7.88M | -8.67M |
| Depreciation & Amortization | 70.56K | 0 | 0 | 0 | 0 | 0 | 26.9K | 0 | 16.17K | 18.94K | 15.82K | 15.85K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -6.52M | 1.75M | 2.1M | 3.31M | 2.99M | 3.49M | 3.59M | 3.91M | 91.5K | 201.59K | 628.6K | 479.47K |
| Working Capital Changes | -2.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -556.44K | -1.28M | -167.08K | 1.06M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -178.4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -223.84K | -1.6M | 128.3K | 524.05K |
| Cash from Investing | 5.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.86M | 3.92M | -4.24M | 14.3M |
| Capital Expenditures | -3.02K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -29 | 7 | -1.98K | -990 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 7.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.14M | 5.74K | 1.35M | -2.97K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.94K | -2.97K | -2.97K |
| Equity Issued (Net) | 7.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.14M | -198 | 1.35M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 440.87K | 1.53M | -2.88M | 2.33M | -529.03K | 1.57M | 369.98K | -4.63M | 140.2K | -1.23M | -10.39M | 7.25M |
| Free Cash Flow | -11.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.9M | -5.13M | -7.4M | -7.12M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | - | - | - | - | 100% | 100% | 100% | 100% | 32.66% | 0.96% | -31.32% | -90.03% |
| FCF per Share | -1.43 | - | - | - | - | - | - | - | -1.20 | -1.74 | -2.67 | -2.58 |
| FCF Conversion (FCF/Net Income) | 5.95x | - | - | - | - | - | - | - | 1.13x | 1.26x | 0.93x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |